Triple Negative Breast Cancer

被引:36
|
作者
Cetin, Idil [1 ]
Topcul, Mehmet [2 ]
机构
[1] Istanbul Univ, Fac Sci, Dept Radiobiol, Istanbul, Turkey
[2] Istanbul Univ, Fac Sci, Dept Biol, Istanbul, Turkey
关键词
Triple negative breast cancer; poor prognosis; targeted therapy; ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; MOLECULAR SUBTYPES; RISK-FACTORS; STEM-CELLS; PROGNOSTIC VALUE; BASAL; CHEMOTHERAPY; CARCINOMA; SURVIVAL;
D O I
10.7314/APJCP.2014.15.6.2427
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Triple-negative breast cancers (TNBC), characterized by absence of the estrogen receptor (ER) and progesterone receptor (PR) and lack of overexpression of human epidermal growth factor receptor 2 (HER2), have a poor prognosis. To overcome therapy limitations of TNBC, various new approaches are needed. This mini-review focuses on discovery of new targets and drugs which might offer new hope for TNBC patients.
引用
收藏
页码:2427 / 2431
页数:5
相关论文
共 50 条
  • [1] Understanding the biology of triple-negative breast cancer
    Criscitiello, C.
    Azim, H. A., Jr.
    Schouten, P. C.
    Linn, S. C.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 13 - 18
  • [2] Triple Negative Breast Cancer: Therapeutic and Prognostic Implications
    Brady-West, Doreen C.
    McGrowder, Donovan A.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (08) : 2139 - 2143
  • [3] Triple-negative breast cancer in the older population
    Boyle, P.
    ANNALS OF ONCOLOGY, 2012, 23 : 7 - 12
  • [4] Basal/Triple Negative Breast Cancer
    Liedtke, C.
    Kiesel, L.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2009, 69 (04) : 309 - 315
  • [5] Triple negative breast cancer in Asia: An insider's view
    Wang, Chao
    Kar, Shreya
    Lai, Xianning
    Cai, Wanpei
    Arfuso, Frank
    Sethi, Gautam
    Lobie, Peter E.
    Goh, Boon C.
    Lim, Lina H. K.
    Hartman, Mikael
    Chan, Ching W.
    Lee, Soo C.
    Tan, Sing H.
    Kumar, Alan P.
    CANCER TREATMENT REVIEWS, 2018, 62 : 29 - 38
  • [6] The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment
    Fornier, Monica
    Fumoleau, Pierre
    BREAST JOURNAL, 2012, 18 (01) : 41 - 51
  • [7] The hispanic landscape of triple negative breast cancer
    Zevallos, Alejandra
    Bravo, Leny
    Bretel, Denisse
    Paez, Kevin
    Infante, Ulises
    Cardenas, Nadezhda
    Alvarado, Hober
    Posada, Ana M.
    Pinto, Joseph A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 155
  • [8] Triple negative breast cancer: the kiss of death
    Jitariu, Adriana-Andreea
    Cimpean, Anca Maria
    Ribatti, Domenico
    Raica, Marius
    ONCOTARGET, 2017, 8 (28) : 46652 - 46662
  • [9] Molecular targets and therapeutic strategies for triple-negative breast cancer
    Bhat, Yashasvi
    Thrishna, M. R.
    Banerjee, Satarupa
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (12) : 10535 - 10577
  • [10] Novel therapeutic strategies in the treatment of triple-negative breast cancer
    Oualla, Karima
    El-Zawahry, Heba M.
    Arun, Banu
    Reuben, James M.
    Woodward, Wendy A.
    El-Din, Heba Gamal
    Lim, Bora
    Mellas, Nawfel
    Ueno, Naoto T.
    Fouad, Tamer M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (07) : 493 - 511